Articles

Cover Corona Outbreak Impact: Biosensors Market is Expected to Boom in Coming Years

by Pramod Kumar Digital Marketing Professional

In 2018, the global biosimilars market attained a value of $6.0 billion and is projected to register a 29.6% CAGR during the forecast period (2019–2024). The market is registering growth due to the inexpensive nature of biosimilar drugs, increasing geriatric population, rising research & development (R&D) investment by biopharmaceutical companies and extensive pipeline of biosimilars, and rising prevalence of chronic diseases. Generic equivalents of biologics are referred to as biosimilars. They are highly similar and comparable version of an approved biologic medicine and undergo clinical trials for demonstrating efficacy and safety.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/biosimilars-market/report-sample

When technology is taken into consideration, the biosimilars market is divided into electrophoresis, monoclonal antibody (mAb), nuclear magnetic resonance, recombinant deoxyribonucleic acid, and bioassays. Out of these, the mAb technology dominated the market during the historical period 2014–2018 and is expected to account for the major share of the market during the forecast period as well. This is because of the increasing utilization of mAbs and technological advancements in the field. The division is further predicted to grow at the fastest pace during the forecast period.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=biosimilars-market

Geographically, Europe accounted for the major share of the biosimilars market during the historical period and is expected to contribute the largest revenue share to the market during the forecast period as well. This is attributed to the rising prevalence of chronic diseases, presence of established players, and growing geriatric population. Furthermore, partnerships and collaborations among the players in the region is predicted to create opportunities for the players in the market. North America is projected to advance at the fastest pace during the forecast period because of the rising number of product approvals.

Hence, the market is being driven by the rising R&D investments and growing prevalence of chronic diseases. 


Sponsor Ads


About Pramod Kumar Advanced   Digital Marketing Professional

89 connections, 2 recommendations, 268 honor points.
Joined APSense since, July 17th, 2017, From Ave, United States.

Created on Dec 7th 2020 04:07. Viewed 203 times.

Comments

No comment, be the first to comment.
Please sign in before you comment.